# ZNF501

## Overview
ZNF501 is a gene that encodes the zinc finger protein 501, a transcription factor characterized by its zinc finger motifs, which facilitate DNA binding and transcriptional regulation. This protein is primarily localized in the nucleus, with a notable presence in the nucleoli, suggesting its involvement in regulating gene expression and maintaining cellular homeostasis (Serebrenik2018Targeted). ZNF501 plays a crucial role in the structural integrity and function of the Golgi apparatus, impacting protein processing and trafficking (Serebrenik2018Targeted). It is implicated in various biological processes, including immune and inflammatory responses, and is associated with several conditions such as autism spectrum condition, depression, and cancer (Sun2023Shared; Li2021Transcriptomewide; Zhuo2023Identification). Through its regulatory functions, ZNF501 contributes to complex transcriptional networks that influence both normal cellular functions and disease pathogenesis.

## Function
ZNF501 is a zinc finger protein that plays a significant role in transcriptional regulation within healthy human cells. It is involved in maintaining the structural integrity and function of the Golgi apparatus, a critical organelle for protein processing and trafficking. Knockdown experiments have shown that reducing ZNF501 expression leads to increased Golgi fragmentation and decreased secretion of proteins, indicating its essential role in Golgi function (Serebrenik2018Targeted). 

ZNF501 is localized to the nucleus, with a particular enrichment in the nucleoli, suggesting its involvement in transcriptional regulation processes. This localization implies that ZNF501 may influence gene expression by interacting with DNA or other nuclear components (Serebrenik2018Targeted). 

In addition to its role in the Golgi apparatus, ZNF501 has been implicated in broader transcriptional activities. It is predicted to act as a transcriptional activator, although its activity levels can vary depending on the cellular context, indicating potential dependencies on other factors or conditions (Moyers2023Characterization). These functions highlight ZNF501's importance in cellular homeostasis and its potential impact on various biological processes.

## Clinical Significance
ZNF501 has been implicated in several conditions through its role in gene expression regulation. A transcriptome-wide association study identified ZNF501 as a gene associated with depression, suggesting that it may confer risk by regulating gene expression in the brain. The study found that ZNF501 expression is higher in the prenatal developing human brain compared to the adult brain, indicating its potential involvement in developmental processes related to depression (Li2021Transcriptomewide).

In the context of autism spectrum condition (ASC), ZNF501 was identified as one of the differentially expressed genes in a study involving identical twins discordant for ASC. This suggests a potential role in transcriptional dysregulation associated with the condition, although the specific mechanisms remain unclear (Saffari2019RNA).

ZNF501 has also been identified as a transcription factor involved in the regulatory network associated with Wilms tumor, indicating its involvement in cancer-related pathways (Zhuo2023Identification). Additionally, ZNF501 is part of a transcription factor network that may contribute to the pathogenesis of diseases such as diabetes, inflammatory disorders, cardiovascular disease, and cancers (Sun2023Shared).

## Interactions
ZNF501, a zinc finger protein, is involved in various interactions that influence gene expression and cellular processes. It functions as a transcription factor, targeting multiple genes and playing a role in immune and inflammatory responses (Sun2023Shared). ZNF501 is implicated in the regulation of expression and translation, particularly in the context of autism spectrum condition (ASC), where it is associated with immune signaling (Saffari2019RNA).

In the context of primary open angle glaucoma (POAG) and atherosclerosis (AS), ZNF501 is identified as a transcription factor targeting shared hub genes involved in oxidative stress and inflammatory responses (Sun2023Shared). This suggests its participation in regulatory networks that may contribute to the pathogenesis of these conditions.

ZNF501 is also highlighted in studies related to depression, where it is suggested to confer risk by regulating gene expression, particularly in the prenatal developing human brain (Li2021Transcriptomewide). Although specific protein-protein interactions involving ZNF501 are not detailed, its role as a transcription factor indicates its involvement in complex regulatory networks that modulate various biological processes.


## References


[1. (Li2021Transcriptomewide) Xiaoyan Li, Xi Su, Jiewei Liu, Huijuan Li, Ming Li, Wenqiang Li, and Xiong-Jian Luo. Transcriptome-wide association study identifies new susceptibility genes and pathways for depression. Translational Psychiatry, May 2021. URL: http://dx.doi.org/10.1038/s41398-021-01411-w, doi:10.1038/s41398-021-01411-w. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41398-021-01411-w)

[2. (Moyers2023Characterization) Belle A. Moyers, E. Christopher Partridge, Mark Mackiewicz, Michael J. Betti, Roshan Darji, Sarah K. Meadows, Kimberly M. Newberry, Laurel A. Brandsmeier, Barbara J. Wold, Eric M. Mendenhall, and Richard M. Myers. Characterization of human transcription factor function and patterns of gene regulation in hepg2 cells. Genome Research, 33(11):1879–1892, October 2023. URL: http://dx.doi.org/10.1101/gr.278205.123, doi:10.1101/gr.278205.123. This article has 3 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1101/gr.278205.123)

[3. (Zhuo2023Identification) Yingquan Zhuo, Wengqi Zhang, Jun Du, Hua Jiang, Guangtang Chen, Xiaoyun Feng, and Huajian Gu. Identification of m6a-associated genes as prognostic and immune-associated biomarkers in wilms tumor. Discover Oncology, November 2023. URL: http://dx.doi.org/10.1007/s12672-023-00817-w, doi:10.1007/s12672-023-00817-w. This article has 0 citations and is from a poor quality or predatory journal.](https://doi.org/10.1007/s12672-023-00817-w)

[4. (Saffari2019RNA) Ayden Saffari, Matt Arno, Eric Nasser, Angelica Ronald, Chloe C. Y. Wong, Leonard C. Schalkwyk, Jonathan Mill, Frank Dudbridge, and Emma L. Meaburn. Rna sequencing of identical twins discordant for autism reveals blood-based signatures implicating immune and transcriptional dysregulation. Molecular Autism, November 2019. URL: http://dx.doi.org/10.1186/s13229-019-0285-1, doi:10.1186/s13229-019-0285-1. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13229-019-0285-1)

5. (Sun2023Shared) Shared Molecular Mechanisms Between Primary open angle glaucoma and Atherosclerosis via Integrated Bioinformatic Analysis. This article has 0 citations.

[6. (Serebrenik2018Targeted) Yevgeniy V. Serebrenik, Doris Hellerschmied, Momar Toure, Francesc López-Giráldez, Dennis Brookner, and Craig M. Crews. Targeted protein unfolding uncovers a golgi-specific transcriptional stress response. Molecular Biology of the Cell, 29(11):1284–1298, June 2018. URL: http://dx.doi.org/10.1091/mbc.E17-11-0693, doi:10.1091/mbc.e17-11-0693. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.E17-11-0693)